Printer Friendly

Articles from SciTech21 (November 17, 2006)

1-8 out of 8 article(s)
Title Author Type Words
AVANIR Pharmaceuticals Added to NASDAQ Biotechnology Index. 163
BIOTECH COMPANIES IN THE NEWS: AVANIR Pharmaceuticals. 291
Enrollment of New Patients Discontinued in Becatecarin Trial. 180
FDA Approves Genentech's Breast Cancer Drug. 553
Florida Atlantic University Receives $5 Million to Study Ocean Currents as Energy Source. 692
Natural Plastic Developer Metabolix Completes IPO. 263
Seattle Genetics Begins Phase I Trial of Hodgkin's Disease Treatment. 346
Tissue Damage Treatment from FibroGen Shows Promise in Acute Kidney Injury Study. 241

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |